Mechanism of Action of Leflunomide

Introduction

Leflunomide is an immunomodulatory and disease-modifying antirheumatic drug (DMARD) used primarily in the treatment of rheumatoid arthritis and psoriatic arthritis. It suppresses immune cell proliferation and reduces inflammation, thereby slowing disease progression and joint damage.


MOA of Leflunomide
Mechanism of Action of Leflunomide
Leflunomide pharmacology
Leflunomide clinical pharmacology
Mechanism of Action of Leflunomide Flowchart
FLOWCHART of mechanism of action of Leflunomide

Mechanism of Action (Step-wise)

  1. Prodrug Conversion
    Leflunomide is converted in the body to its active metabolite, teriflunomide (A77 1726).
  2. Inhibition of Dihydroorotate Dehydrogenase (DHODH)
    Teriflunomide inhibits DHODH, a key mitochondrial enzyme involved in de novo pyrimidine synthesis.
  3. Reduction in Pyrimidine Nucleotide Production
    Inhibition of DHODH decreases the synthesis of uridine monophosphate (UMP), leading to reduced DNA and RNA synthesis.
  4. Inhibition of Lymphocyte Proliferation
    Activated T and B lymphocytes rely heavily on de novo pyrimidine synthesis; their proliferation is selectively inhibited.
  5. Suppression of Autoimmune Response
    Reduced lymphocyte activity decreases the autoimmune response seen in rheumatoid arthritis.
  6. Anti-inflammatory Effects
    Leflunomide reduces production of pro-inflammatory cytokines and mediators.

Pharmacokinetics

  • Administration: Oral
  • Absorption: Well absorbed
  • Conversion: Rapid conversion to active metabolite
  • Protein Binding: High
  • Half-life: Long (~2 weeks)
  • Excretion: Biliary and renal

Clinical Uses

  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Autoimmune disorders (off-label)

Adverse Effects

  • Hepatotoxicity
  • Diarrhea
  • Hypertension
  • Teratogenicity
  • Bone marrow suppression
  • Alopecia

Comparative Analysis

FeatureLeflunomideMethotrexateSulfasalazine
ClassDMARDDMARDDMARD
MechanismDHODH inhibitionFolate antagonistAnti-inflammatory
Effect on lymphocytesInhibits proliferationInhibits DNA synthesisModerate effect
HepatotoxicityYesYesMild
UseRA, psoriatic arthritisRA, cancerRA, IBD

Leflunomide selectively inhibits lymphocyte proliferation by targeting pyrimidine synthesis, whereas methotrexate acts as a folate antagonist. It is often used as an alternative or adjunct in rheumatoid arthritis management.


MCQs

  1. Leflunomide inhibits which enzyme?
    a) DNA polymerase
    b) DHODH
    c) Topoisomerase
    d) Cyclooxygenase
    Answer: b) DHODH
  2. Active metabolite of leflunomide:
    a) Methotrexate
    b) Teriflunomide
    c) Azathioprine
    d) Cyclophosphamide
    Answer: b) Teriflunomide
  3. Mechanism involves inhibition of:
    a) Purine synthesis
    b) Pyrimidine synthesis
    c) Protein synthesis
    d) Lipid synthesis
    Answer: b) Pyrimidine synthesis
  4. Main effect on immune cells:
    a) Activation
    b) Proliferation inhibition
    c) Differentiation
    d) Apoptosis only
    Answer: b) Proliferation inhibition
  5. Leflunomide is used in:
    a) Diabetes
    b) Hypertension
    c) Rheumatoid arthritis
    d) Asthma
    Answer: c) Rheumatoid arthritis
  6. Major toxicity:
    a) Nephrotoxicity
    b) Hepatotoxicity
    c) Ototoxicity
    d) Cardiotoxicity
    Answer: b) Hepatotoxicity
  7. Half-life of active metabolite:
    a) Short
    b) Moderate
    c) Long
    d) Very short
    Answer: c) Long
  8. Teratogenic effect requires:
    a) Dose reduction
    b) Immediate discontinuation
    c) Monitoring only
    d) No action
    Answer: b) Immediate discontinuation
  9. Leflunomide affects:
    a) RBCs only
    b) T and B lymphocytes
    c) Platelets only
    d) Neurons only
    Answer: b) T and B lymphocytes
  10. It belongs to:
    a) NSAIDs
    b) DMARDs
    c) Antibiotics
    d) Antivirals
    Answer: b) DMARDs

FAQs

  1. What is the mechanism of action of leflunomide?
    It inhibits DHODH, reducing pyrimidine synthesis and lymphocyte proliferation.
  2. Why is leflunomide effective in rheumatoid arthritis?
    It suppresses immune-mediated inflammation by inhibiting lymphocyte activity.
  3. What is teriflunomide?
    The active metabolite responsible for pharmacological effects.
  4. Why is leflunomide teratogenic?
    It interferes with DNA synthesis and cell proliferation.
  5. Does leflunomide affect purine synthesis?
    No, it mainly affects pyrimidine synthesis.
  6. What is a major concern during therapy?
    Hepatotoxicity and monitoring liver function.

References

Author

  • Harsh Singh Author Pharmacy Freak

    Harsh Singh Rajput is a pharmacist currently working at ESIC and holds an MBA in Pharmaceutical Management from NIPER Hyderabad. He has a strong academic record with top ranks in national-level pharmacy exams, including AIR 61 in NIPER 2024 (MS/M.Pharm), AIR 27 in NIPER MBA, AIR 147 in GPAT 2024, AIR 907 in GPAT 2023, and AIR 6 in AIIMS CRE-2025 for Drug Store Keeper. At PharmacyFreak.com, he contributes expert content, exam strategies, and practical guidance for future pharmacists.
    Mail- harsh@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators